Literature DB >> 22978320

Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis.

R Pezato1, M Świerczyńska-Krępa, E Niżankowska-Mogilnicka, L Derycke, C Bachert, C A Pérez-Novo.   

Abstract

Chronic rhinosinusitis (CRS) is a multifactorial disease of the upper airways with a high prevalence (approximately 11%) in the general population. Different immune and inflammatory mechanisms are involved in its pathogenesis. Alterations in the arachidonic acid pathway (leading to an imbalanced production of eicosanoids) have been linked to the pathophysiology of different diseases especially nasal polyposis, asthma, and aspirin-exacerbated respiratory disease. Furthermore, viral and bacterial infections have been identified as important factors amplifying the pro-inflammatory reactions in these pathologies. This review summarizes the impact of an imbalance in the eicosanoid pathway and the effect of Staphylococcus aureus enterotoxins on the regulation of the pro-inflammatory network in CRS and their translation into disease severity.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978320     DOI: 10.1111/all.12010

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  13 in total

Review 1.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

Review 2.  Trained immunity in type 2 immune responses.

Authors:  Franziska Hartung; Julia Esser-von Bieren
Journal:  Mucosal Immunol       Date:  2022-09-05       Impact factor: 8.701

3.  Clinical features of elderly chronic urticaria.

Authors:  Ga-Young Ban; Mi-Yea Kim; Hye-Soo Yoo; Dong-Ho Nahm; Young-Min Ye; Yoo-Seob Shin; Hae-Sim Park
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

4.  Nasal Polyp-Derived Mesenchymal Stromal Cells Exhibit Lack of Immune-Associated Molecules and High Levels of Stem/Progenitor Cells Markers.

Authors:  Pedro Wey Barbosa de Oliveira; Rogério Pezato; Juan Sebastian Henao Agudelo; Claudina Angela Perez-Novo; Wim Vanden Berghe; Niels Olsen Câmara; Danilo Candido de Almeida; Luís Carlos Gregorio
Journal:  Front Immunol       Date:  2017-01-30       Impact factor: 7.561

5.  Linking Complement C3 and B Cells in Nasal Polyposis.

Authors:  Ulrike Werner; Axel Künstner; Maren Drenckhan; Ralph Pries; Karl-Ludwig Bruchhage; Hauke S Busch; Claus Bachert; Barbara Wollenberg
Journal:  J Immunol Res       Date:  2020-07-08       Impact factor: 4.818

6.  Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma.

Authors:  Luo Zhang; Chengshuo Wang; Ming Wang; Xiangting Bu; Ge Luan; Liqing Lin; Yang Wang; Jianmin Jin
Journal:  Clin Transl Allergy       Date:  2020-07-03       Impact factor: 5.871

7.  Understanding resolvin signaling pathways to improve oral health.

Authors:  David Keinan; Noel J Leigh; Joel W Nelson; Laura De Oleo; Olga J Baker
Journal:  Int J Mol Sci       Date:  2013-03-08       Impact factor: 5.923

8.  Bone: the final frontier for Staphylococcus aureus penetration in chronic rhinosinusitis.

Authors:  Rogério Pezato; Luciano Bottura; Rodrigo de Paula Santos; Richard Louis Voegels; Andre Luis Lacerda Bachi; Luis Carlos Gregório
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-07-19

9.  Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment.

Authors:  Rogério Pezato; Danilo Cândido de Almeida; Thiago Freire Bezerra; Fernando de Sá Silva; Claudina Perez-Novo; Luís Carlos Gregório; Richard Louis Voegels; Niels Olsen Câmara; Claus Bachert
Journal:  Mediators Inflamm       Date:  2014-02-13       Impact factor: 4.711

Review 10.  Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.

Authors:  Carlos A M Silva; John T Belisle
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.